*Department of Pharmaceutical Analysis and Nuclear Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava;

†Toxicological and Antidoping Center, Faculty of Pharmacy, Comenius University in Bratislava;

‡Slovak Academy of Sciences, Institute of Neuroimmunology;

¶Department of Hematology and Transfusiology, University Hospital, Bratislava, Slovak Republic; and

§SK-Lab S.r.o., Lucenec, Slovak Republic.

Correspondence: Andrej Kovac, PharmD, PhD, Slovak Academy of Sciences, Institute of Neuroimmunology, Dubravska Cesta 9, SK-845 10 Bratislava, Slovak Republic (e-mail: [email protected]).

Supported by research grants VEGA 2/0129/21, APVV-16-0531, APVV-18-0302, VEGA 1/0514/22, and KEGA 027UK-4/2020.

The authors declare no conflict of interest.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.drug-monitoring.com).